Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea.
Fibronostics' LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool.
Fibronostics' HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients' risk levels and drive better patient care.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 3452 Lake Lynda Dr,
- Phone
- (888) 552-1603
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.fibronostics.com
- Keywords
- liver, liver health, liver disease, nafld, artificial intelligence, machine learning, non invasive, nash, med tech.
- HQ
- Orlando, Florida
Fibronostics Questions
Fibronostics's helpline number is (888) 552-1603
Fibronostics's website is http://www.fibronostics.com
Fibronostics's LinkedIn profile is https://www.linkedin.com/company/fibronostics
Fibronostics has
26 employees.
View email and phone details for 26
employees at Fibronostics.
Fibronostics's industry is
Hospitals and Health Care
Fibronostics's top competitors are
Veloxis Pharmaceuticals, Inc.,
Curium Pharma,
Verona Pharma,
Pluvia.ai,
Xeris Pharmaceuticals, Inc.,
Ampersand Capital Partners,
Obviohealth,
Stone Diagnostics,
Clarity Pharmaceuticals,
Alpha Cognition, Inc..
Fibronostics's categories are Hospitals and Health Care
Fibronostics's founding year is 2015
